» Articles » PMID: 22347476

Mutations in Human αA-crystallin/sHSP Affect Subunit Exchange Interaction with αB-crystallin

Overview
Journal PLoS One
Date 2012 Feb 21
PMID 22347476
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mutation in αA-crystallin contributes to the development of congenital cataract in humans. Heterooligomerization of αA-crystallin and αB-crystallin is essential for maintaining transparency in the eye lens. The effect of congenital cataract causing mutants of αA-crystallin on subunit exchange and interaction with αB-crystallin is unknown. In the present study, interaction of the mutants of αA-crystallin with αB-crystallin was studied both in vitro and in situ by the fluorescence resonance energy transfer (FRET) technique.

Methodology/principal Findings: In vitro FRET technique was used to demonstrate the rates of subunit exchange of αB-wt with the following αA-crystallin mutants: R12C, R21L, R21W, R49C, R54C, and R116C. The subunit exchange rates (k values) of R21W and R116C with αB-wt decreased drastically as compared to αA-wt interacting with αB-wt. Moderately decreased k values were seen with R12C, R49C and R54C while R21L showed nearly normal k value. The interaction of αA- mutants with αB-wt was also assessed by in situ FRET. YFP-tagged αA mutants were co-expressed with CFP-tagged αB-wt in HeLa cells and the spectral signals were captured with a confocal microscope before and after acceptor laser photobleaching. The interaction of R21W and R116C with αB-wt was decreased nearly 50% as compared to αA-wt while the rest of the mutants showed slightly decreased interaction. Thus, there is good agreement between the in vitro and in situ FRET data.

Conclusions/significance: Structural changes occurring in these mutants, as reported earlier, could be the underlying cause for the decreased interaction with αB may contribute to development of congenital cataract.

Citing Articles

Identification of mutations associated with congenital cataracts in nineteen Chinese families.

Sun H, Huang T, Liu Z, Xu Y, Wang Y, Wang M BMC Ophthalmol. 2025; 25(1):94.

PMID: 39994538 PMC: 11853334. DOI: 10.1186/s12886-025-03920-4.


Study of The Molecular Nature of Congenital Cataracts in Patients from The Volga-Ural Region.

Khidiyatova I, Khidiyatova I, Zinchenko R, Marakhonov A, Karunas A, Avkhadeeva S Curr Issues Mol Biol. 2023; 45(6):5145-5163.

PMID: 37367076 PMC: 10297118. DOI: 10.3390/cimb45060327.


Congenital cataract - clinical and morphological aspects.

Tataru C, Tataru C, Costache A, Boruga O, Zemba M, Ciuluvica R Rom J Morphol Embryol. 2020; 61(1):105-112.

PMID: 32747900 PMC: 7728133. DOI: 10.47162/RJME.61.1.11.


The multifaceted nature of αB-crystallin.

Hayashi J, Carver J Cell Stress Chaperones. 2020; 25(4):639-654.

PMID: 32383140 PMC: 7332646. DOI: 10.1007/s12192-020-01098-w.


A novel mutation in the CRYAA gene associated with congenital cataract and microphthalmia in a Chinese family.

Song Z, Si N, Xiao W BMC Med Genet. 2018; 19(1):190.

PMID: 30340470 PMC: 6194747. DOI: 10.1186/s12881-018-0695-5.


References
1.
Lindner R, Treweek T, Carver J . The molecular chaperone alpha-crystallin is in kinetic competition with aggregation to stabilize a monomeric molten-globule form of alpha-lactalbumin. Biochem J. 2001; 354(Pt 1):79-87. PMC: 1221631. DOI: 10.1042/0264-6021:3540079. View

2.
Bova M, Ding L, Horwitz J, Fung B . Subunit exchange of alphaA-crystallin. J Biol Chem. 1997; 272(47):29511-7. DOI: 10.1074/jbc.272.47.29511. View

3.
Wang K, Spector A . The chaperone activity of bovine alpha crystallin. Interaction with other lens crystallins in native and denatured states. J Biol Chem. 1994; 269(18):13601-8. View

4.
van der Ouderaa F, de Jong W, Bloemendal H . The amino-acid sequence of the alphaA2 chain of bovine alpha-crystallin. Eur J Biochem. 1973; 39(1):207-22. DOI: 10.1111/j.1432-1033.1973.tb03119.x. View

5.
Xia C, Liu H, Chang B, Cheng C, Cheung D, Wang M . Arginine 54 and Tyrosine 118 residues of {alpha}A-crystallin are crucial for lens formation and transparency. Invest Ophthalmol Vis Sci. 2006; 47(7):3004-10. DOI: 10.1167/iovs.06-0178. View